Prostate Cancer - Results from #40

Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer. December 17, 2024

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial. December 17, 2024

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer. December 17, 2024

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate. December 17, 2024

Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis. December 17, 2024

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI. December 16, 2024

Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance. December 16, 2024

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer. December 16, 2024

Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. December 16, 2024

Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. December 16, 2024

Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial. December 16, 2024

Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit. December 13, 2024

Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. December 13, 2024

Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair Analysis. December 13, 2024

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. December 13, 2024

Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors. December 13, 2024

Racial Disparities in Future Development of Lethal Prostate Cancer Based on Midlife Baseline Prostate-Specific Antigen. December 12, 2024

Impact of Discordance Between MRI and US Volume Measurements on Prostate Fusion Biopsy Outcomes. December 12, 2024

How Prostate Cancer Growth Patterns Impact Detection and Interreader Agreement on Multiparametric MRI. December 12, 2024

Minimizing infectious complications following transrectal prostate biopsy: a proposal for a risk-adapted antibiotic treatment strategy with Ceftriaxone and Ertapenem as key components. December 12, 2024

Page 3 of 1447